A new approach to diagnosing obesity could help prevent millions of people worldwide from being incorrectly classified, with medical experts calling for doctors to look beyond body mass index (BMI) when assessing excess body fat.
The proposed method combines BMI with additional body measurements and tests of organ function. Researchers say the approach could help identify people whose health is being affected by excess body fat while avoiding unnecessary obesity diagnoses in people who are otherwise healthy.
Medical experts have long questioned the accuracy of BMI as a standalone measure of obesity. The traditional calculation uses a person’s weight in kilograms divided by their height in metres squared, but it does not directly measure body fat or establish whether excess fat is affecting someone’s health.
According to the researchers, BMI alone misses obesity in between 5% and 9% of adults, while incorrectly identifying the condition in as many as 3%.
Francisco Rubino, a professor of metabolic and bariatric surgery at King’s College London, said the misclassification could affect tens of millions of people, making BMI’s limitations significant both for individuals and across populations.
The researchers examined health records from more than 800,000 people in the United Kingdom, United States, China and Spain. Their analysis, which tracked people’s health for up to 15 years, tested a diagnostic approach proposed by Rubino and other international experts in a Lancet Commission report the previous year.
Under the proposed definition, people with a BMI above 40 are classified as having obesity. For those with lower BMI measurements, doctors would also examine waist circumference and the relationship between waist size and height.
A BMI of 30 or higher, combined with an elevated waist measurement or waist-to-height ratio, would qualify as obesity. People with a BMI between 25 and 29.9 could also receive an obesity diagnosis if both their waist measurement and waist-to-height ratio were high.
In most countries, an elevated waist measurement is defined as more than 102 centimetres for men and 88 centimetres for women. A waist-to-height ratio of approximately 0.57 is considered high under the approach described by the researchers.
The assessment then moves beyond body measurements to examine whether excess body fat is already affecting the body’s organs and physical functions.
This distinction separates clinical obesity from pre-clinical obesity. Clinical obesity describes a condition in which excess body fat is already impairing organ function, while pre-clinical obesity refers to excess body fat that presents a health risk but has not yet caused detectable problems with organ function.
The findings suggest that only around a quarter to a third of people classified as having obesity under the new definition had clinical obesity and a substantially higher risk of death. This group represented approximately 5% to 10% of the wider population.
The approach also highlights how people with identical BMI measurements can have very different health conditions.
For example, three people with a BMI of 32 could receive different assessments. One might have no excess body fat and remain healthy. Another might have excess body fat but no evidence of organ dysfunction, placing them in the pre-clinical category. The third could have excess body fat that is already affecting organ function, meeting the definition of clinical obesity.
Writing in Nature, the researchers also reported that some people with high BMI measurements were not considered obese under the alternative definition and had a lower risk of death than some people classified as healthy.
Another finding was that between 80% and 90% of people with pre-clinical obesity did not progress to clinical obesity during the following 10 years.
Although the proposed method requires more detailed assessments from healthcare professionals, Rubino said individual diagnosis could help doctors select more appropriate treatments.
Depending on a person’s circumstances, interventions could include lifestyle advice, GLP-1 weight-loss medications or surgery.
He argued that a more accurate diagnosis could help improve treatment safety and effectiveness while making better use of healthcare resources.
The researchers say moving beyond BMI alone could allow doctors to distinguish more accurately between people who have excess body fat and those whose health is already being affected by it.
